Cargando…
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
We evaluated risk factors and treatment outcomes associated with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in Germany in 2004–2006. In 177 (4%) of 4,557 culture-positive TB cases, Mycobacterium tuberculosis isolates were identified as MDR TB; an additional 7 (0...
Autores principales: | Eker, Barbara, Ortmann, Johannes, Migliori, Giovanni B., Sotgiu, Giovanni, Muetterlein, Ralf, Centis, Rosella, Hoffmann, Harald, Kirsten, Detlef, Schaberg, Tom, Ruesch-Gerdes, Sabine, Lange, Christoph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630755/ https://www.ncbi.nlm.nih.gov/pubmed/18976552 http://dx.doi.org/10.3201/eid1411.080729 |
Ejemplares similares
-
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016) -
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017) -
Risk for latent and active tuberculosis in Germany
por: Herzmann, Christian, et al.
Publicado: (2016) -
Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
por: Sotgiu, Giovanni, et al.
Publicado: (2021) -
Extensively Drug-resistant Tuberculosis, Italy and Germany
por: Migliori, Giovanni Battista, et al.
Publicado: (2007)